Enter your search term below:
Developed by ISCT Business Development & Finance Committee The year 2025 marked a notable period of momentum for the cell and gene therapy (CGT) sector, characterised by significant deal making across multiple therapeutic modalities. In 2025, the field saw approximately USD 12 billion...
Fajar Dumadi, BSc International Society for Cell & Gene Therapy (ISCT) Canada Following the release of the latest edition of the ISCT CGT Global Regulatory Report —presenting a comprehensive year-end review of 2025—we are proud to share a significant milestone for the Society and its...
Tuula Rintala Director, Quality of Care and Advocacy EBMT, European Society for Blood and Marrow Transplantation Spain CAR-T cell therapy has transformed the treatment landscape for patients with haematological malignancies, but its promise can only be fully realised when every healthcare...
Introduction In the rapidly evolving landscape of advanced therapies, few challenges are as complex — or as consequential — as scaling cell therapy manufacturing to meet growing clinical and commercial demand. In this expert analysis, the team at AGC Biologics shares their perspective on...
Madhavi Lakkaraja, MD, MPH Fred Hutchinson Cancer Center, University of Washington School of Medicine United States From ISCT 2025 Roundtable Session: Cell Therapies to Manage GVHD - Learning From Pivotal Approvals 1. How the Biology of Acute Graft Versus Host Disease (GVHD) Makes It...
May 12, 2026 - Sep 05, 2026
Hannah Song, PhD Contributing Editor, ISCT Telegraft National Institutes of Health United States It is my great honor and privilege to write to you today as a newly-minted Telegraft Editorial Board member! I’ve been part of the ISCT community for 5 years and involved in cell and gene...
Medhat Askar, MD, PhD, MSHPE, FRCPath Member, ISCT Lab Practices Committee Texas A&M College of Medicine United States Rajdeep Das, MD, PhD, FIBMS Member, ISCT Lab Practices Committee University Hospitals Cleveland Medical Center United States Karen E. Martin, PhD Department of...
Shyam Bhakta, MD, MBA Contributing Editor, ISCT Telegraft United States Dr. Mary Laughlin grew up in Buffalo, NY, where the Roswell Park Cancer Center and Institute is located and where she also completed an internship while in high school. Dr. Laughlin says that at the time, Roswell Park...
Advanced therapy development is no longer limited by whether the science can work. Platform technologies are established, translational pathways are better understood, and the distance between discovery and first-in-human continues to shrink. What now limits progress for many programs is the...